KR20050110103A - Novel process for producing cefonicid intermediate - Google Patents

Novel process for producing cefonicid intermediate Download PDF

Info

Publication number
KR20050110103A
KR20050110103A KR1020040034929A KR20040034929A KR20050110103A KR 20050110103 A KR20050110103 A KR 20050110103A KR 1020040034929 A KR1020040034929 A KR 1020040034929A KR 20040034929 A KR20040034929 A KR 20040034929A KR 20050110103 A KR20050110103 A KR 20050110103A
Authority
KR
South Korea
Prior art keywords
acid
salt
amino
sulfomethyltetrazol
formula
Prior art date
Application number
KR1020040034929A
Other languages
Korean (ko)
Other versions
KR100589559B1 (en
Inventor
나현섭
박민순
이태석
육진수
이완희
Original Assignee
주식회사 엔지켐
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엔지켐 filed Critical 주식회사 엔지켐
Priority to KR1020040034929A priority Critical patent/KR100589559B1/en
Publication of KR20050110103A publication Critical patent/KR20050110103A/en
Application granted granted Critical
Publication of KR100589559B1 publication Critical patent/KR100589559B1/en

Links

Classifications

    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F41WEAPONS
    • F41BWEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR
    • F41B5/00Bows; Crossbows
    • F41B5/0005Single stave recurve bows
    • F41B5/0026Take-down or foldable bows
    • F41B5/0052Limbs
    • F41B5/0057Limbs characterised by the material
    • F41B5/0068Limbs characterised by the material laminated
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2262/00Composition or structural features of fibres which form a fibrous or filamentary layer or are present as additives
    • B32B2262/10Inorganic fibres
    • B32B2262/106Carbon fibres, e.g. graphite fibres
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B3/00Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form
    • B32B3/10Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by a discontinuous layer, i.e. formed of separate pieces of material
    • B32B3/12Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by a discontinuous layer, i.e. formed of separate pieces of material characterised by a layer of regularly- arranged cells, e.g. a honeycomb structure
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/18Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by features of a layer of foamed material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B9/00Layered products comprising a layer of a particular substance not covered by groups B32B11/00 - B32B29/00
    • B32B9/04Layered products comprising a layer of a particular substance not covered by groups B32B11/00 - B32B29/00 comprising such particular substance as the main or only constituent of a layer, which is next to another layer of the same or of a different material
    • B32B9/046Layered products comprising a layer of a particular substance not covered by groups B32B11/00 - B32B29/00 comprising such particular substance as the main or only constituent of a layer, which is next to another layer of the same or of a different material of foam
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B9/00Layered products comprising a layer of a particular substance not covered by groups B32B11/00 - B32B29/00
    • B32B9/04Layered products comprising a layer of a particular substance not covered by groups B32B11/00 - B32B29/00 comprising such particular substance as the main or only constituent of a layer, which is next to another layer of the same or of a different material
    • B32B9/047Layered products comprising a layer of a particular substance not covered by groups B32B11/00 - B32B29/00 comprising such particular substance as the main or only constituent of a layer, which is next to another layer of the same or of a different material made of fibres or filaments

Landscapes

  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

세팔로스포린계 항생제인 세포니시드의 중간체인 하기 화학식 1로 표시되는 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 및 그 염의 신규한 제조방법이 개시된다. 본 발명은 알칸설폰산 용매, 및 삼불화붕소 또는 그 착물의 존재하에서, 7-아미노세팔로스포란산 또는 그 염과 (5-머캅토-테트라졸-1-일)-설폰산 또는 그 염을 반응시키는 단계; 및 상기 반응물에 물, 유기용매 또는 이들의 혼합물, 및 염기성 화합물을 첨가하여 반응물을 결정화하는 단계를 포함한다. 본 발명의 제조방법은 반응의 수율이 높고 부반응이 적어 간단한 정제과정으로 고순도의 세포니시드 중간체를 제조할 수 있다.7-Amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cef-4-carboxylic acid represented by the following Chemical Formula 1, an intermediate of cephalosidide, a cephalosporin-based antibiotic, and its A novel process for preparing salts is disclosed. The present invention provides (5-mercapto-tetrazol-1-yl) -sulfonic acid or salts thereof in the presence of an alkanesulfonic acid solvent and boron trifluoride or a complex thereof. Reacting; And crystallizing the reactant by adding water, an organic solvent or a mixture thereof, and a basic compound to the reactant. In the production method of the present invention, the high yield of the cell nisid intermediate can be prepared by a simple purification process because the reaction yield is high and there are few side reactions.

[화학식 1][Formula 1]

Description

세포니시드 중간체의 신규한 제조방법{novel process for producing cefonicid intermediate}Novel process for producing cefonicid intermediate

본 발명은 세팔로스포린계 항생제인 세포니시드(cefonicid) 중간체의 신규한 제조방법에 관한 것으로서, 더욱 상세하게는 반응의 수율이 높고 부반응이 적어 간단한 정제과정으로 고순도의 세포니시드 중간체 또는 그 염을 제조하는 방법에 관한 것이다.The present invention relates to a novel method for preparing a cefonicid intermediate, a cephalosporin antibiotic, and more particularly, a high purity cenisid intermediate or a salt thereof in a simple purification process due to high yield of reaction and low side reaction. It relates to a method of manufacturing.

세팔로스포린계 항생제는 병원성 박테리아에 의한 감염성 질환의 치료제로서, 특히 페니실린 등의 다른 항생제에 내성이 있는 박테리아에 의한 질환자 및 페니실린 과민성 질환자를 치료하는데 유용한 항생제이다. 그동안 세펨환(cephem ring)의 3번기 또는 7번기에 다양한 치환기를 도입하여, 기존의 항생제에 대해 내성을 지닌 박테리아 또는 보다 넓은 범위의 박테리아에 의한 질환을 치료하기 위한 세팔로스포린계 항생제가 개발되어져 왔으며, 그 예로는 세파졸린, 세파제돈, 세포페라존, 세파만돌, 세파트리진, 세프트리악손, 세포니시드 등이 있다. 이러한 항생제는 그 용도가 동물 및 인체에 투입되어 질환을 치료하는 것이므로, 그 순도가 높아야 하는데, 종래의 제조방법은 부생성물이 많아 수율이 낮고, 정제후에도 최종생성물의 순도가 낮거나 순도가 높더라도 다수의 정제단계를 거쳐야 하므로 경제성이 저하되는 문제점이 있다.Cephalosporin-based antibiotics are therapeutic agents for infectious diseases caused by pathogenic bacteria, and are particularly useful for treating diseases caused by bacteria that are resistant to other antibiotics such as penicillin and penicillin hypersensitivity. Meanwhile, cephalosporin antibiotics have been developed to treat diseases caused by bacteria that are resistant to conventional antibiotics or a wider range of bacteria by introducing various substituents at the 3 or 7 of the cephem ring. Examples include cephazolines, cephazedone, cepharazone, cephamandol, cephatrizin, ceftriaxone, cenisidide and the like. Since these antibiotics are used in animals and humans to treat diseases, the purity of the antibiotics should be high. However, the conventional manufacturing method has a high yield because of a large number of by-products, and even after purification, the purity of the final product is low or high. Since a number of purification steps must be performed, there is a problem that the economic efficiency is lowered.

특히, 세팔로스포린계 항생제의 일종인 세포니시드의 제조방법으로서, 통상적으로 알려진 방법으로는, 중성 또는 약염기성의 물/유기용매 혼합액의 존재 하에서, 7-아미노세팔로스포란산(7-amino cephalosporanic acid)과 (5-머캅토-테트라졸-1-일)-메탄설폰산(5-mercapto-tetrazol-1-yl-methane sulfonic acid)을 반응시켜 7-아미노세팔로스포란산의 3번기에 아세톡시기 대신 (5-머캅토-테트라졸-1-일)-메탄설폰산기을 도입하여 세포니시드의 중간체를 제조하는 방법이 개시되어 있으나(미국특허 제4048311호, 제4159373호), 상기 방법은 반응 완결 후, 다량의 7-아미노세팔로스포란산이 미반응하여 잔존함은 물론, 부반응으로 인한 불순물이 많고, 복잡한 정제과정을 거쳐야 하는 문제점이 있다. 또한 상기 문제점을 보완하기 위하여 아세토니트릴(acetonitrile), 니트로메탄(nitro methane), 초산(acetic acid) 등의 유기용매, 및 삼불화붕소(boran trifluoride) 또는 그 착물(complex) 등 루이스산의 존재하에서 상기 반응물을 반응시켜 세포니시드의 중간체를 제조하는 방법이 개시되어 있으나(미국특허 제4317907호), 여전히 반응의 수율이 낮고, 부반응으로 인한 부생성물이 많아, 고성능 액체크로마토그래피(high performance liquid chromatography: HPLC) 등을 사용하여 정제하여야 하므로 경제성이 저하된다는 문제점이 있다.In particular, a method of producing cenisid, which is a kind of cephalosporin-based antibiotics, is a conventionally known method, which includes 7-aminocephalosporonic acid (7-) in the presence of a neutral or weakly basic water / organic solvent mixture solution. amino cephalosporanic acid) and (5-mercapto-tetrazol-1-yl) -methanesulfonic acid (5-mercapto-tetrazol-1-yl-methane sulfonic acid) to react 3 A method of preparing an intermediate of cenisid by introducing (5-mercapto-tetrazol-1-yl) -methanesulfonic acid group instead of acetoxy group is disclosed (US Pat. No. 4,031,111,4159373). After the completion of the reaction, a large amount of 7-aminocephalosporranic acid remains unreacted, as well as a lot of impurities due to side reactions, there is a problem to undergo a complicated purification process. In addition, in order to solve the above problems, in the presence of an organic solvent such as acetonitrile, nitro methane, acetic acid, and Lewis acid such as borane trifluoride or a complex thereof. Although a method of preparing an intermediate of ceniside by reacting the reactants is disclosed (US Pat. No. 4,397,907), the yield of the reaction is still low, and there are many by-products due to side reactions, and thus high performance liquid chromatography There is a problem that the economical efficiency is lowered because it must be purified by using HPLC).

따라서 본 발명의 목적은 반응의 수율이 높고 부반응이 적어 고순도의 세포니시드 중간체 또는 그 염을 제조하는 방법을 제공하는 것이다. 본 발명의 또다른 목적은 간단한 정제과정만으로 고순도의 세포니시드 중간체 또는 그 염을 제조하는 방법에 관한 것이다. Accordingly, an object of the present invention is to provide a method for producing a high purity cenisid intermediate or salt thereof due to high reaction yield and low side reaction. Another object of the present invention relates to a method for preparing high purity cenisid intermediate or salt thereof by simple purification.

상기 목적을 달성하기 위하여, 본 발명은 알칸설폰산(alkane sulfonic acid) 용매, 및 삼불화붕소 또는 그 착물의 존재하에서, 하기 화학식 2로 표시되는 7-아미노세팔로스포란산 또는 그 염과 하기 화학식 3으로 표시되는 (5-머캅토-테트라졸-1-일)-설폰산 또는 그 염을 반응시키는 단계; 및 상기 반응물에 물, 유기용매 또는 이들의 혼합물, 및 염기성 화합물을 첨가하여 반응물을 결정화하는 단계를 포함하는, 하기 화학식 1로 표시되는 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산(7-amino-3-[1-sulfomethyltetrazol-5ylthiomethyl] -3-cephem-4-carboxylic acid) 및 그 염의 제조방법을 제공한다.In order to achieve the above object, the present invention, in the presence of alkane sulfonic acid solvent, and boron trifluoride or a complex thereof, 7-aminocephalosporranic acid represented by the following formula (2) or salts thereof Reacting (5-mercapto-tetrazol-1-yl) -sulfonic acid or a salt thereof represented by Chemical Formula 3; And crystallizing the reactant by adding water, an organic solvent or a mixture thereof, and a basic compound to the reactant, 7-amino-3- [1-sulfomethyltetrazole-5- It provides a 7-amino-3- [1-sulfomethyltetrazol-5ylthiomethyl] -3-cephem-4-carboxylic acid) and a method for preparing the salt thereof.

상기 화학식 1 내지 3에서, R1 및 R2는 각각 독립적으로 H, Na, K, NH4, Ca 또는 Li이다.In Formulas 1 to 3, R 1 and R 2 are each independently H, Na, K, NH 4 , Ca, or Li.

이하 본 발명을 더욱 상세하게 설명하면 다음과 같다.Hereinafter, the present invention will be described in more detail.

본 발명에 따른 상기 화학식 1로 표시되는 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 및 그 염을 제조하기 위해서는, 먼저 하기 반응식 1에 나타낸 바와 같이, 알칸설폰산 용매, 및 삼불화붕소 또는 그 착물의 존재 하에서, 상기 화학식 2로 표시되는 7-아미노세팔로스포란산 또는 그 염과 상기 화학식 3으로 표시되는 (5-머캅토-테트라졸-1-일)-설폰산 또는 그 염을 반응시킨다.In order to prepare 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cefe-4-carboxylic acid and salts thereof represented by Chemical Formula 1 according to the present invention, As shown in Scheme 1, in the presence of an alkanesulfonic acid solvent and boron trifluoride or a complex thereof, 7-aminocephalosporranic acid represented by Formula 2 or a salt thereof and a compound represented by Formula 3 above (5- Mercapto-tetrazol-1-yl) -sulfonic acid or salt thereof is reacted.

상기 화학식 2로 표시되는 7-아미노세팔로스포란산 또는 그 염은 본 발명에 따른 상기 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산을 제조하기 위한 출발물질로서, 세펨환의 7번기인 아미노기(amino group)가 염산, 황산, p-톨루엔설폰산(p-toluenesulfonic acid), 메탄설폰산(methanesulfonic acid) 등의 산과 반응하여 생성되는 염을 포함할 수 있다.7-Aminocephalosporranic acid represented by the formula (2) or a salt thereof according to the present invention is the 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cefe-4- As a starting material for preparing a carboxylic acid, the amino group, the seventh group of the cefe ring, is reacted with an acid such as hydrochloric acid, sulfuric acid, p-toluenesulfonic acid, and methanesulfonic acid. Salts produced.

상기 화학식 3으로 표시되는 (5-머캅토-테트라졸-1-일)-설폰산 또는 그 염은, 상기 화학식 2로 표시되는 7-아미노세팔로스포란산 또는 그 염의 세펨환의 3번기인 아세톡시기와의 치환반응으로 상기 3번기에 도입되는 반응물로서, 테트라졸환(tetrazole ring)의 1번기인 메틸설폰기(-SO3R1)와 5번기인 티올기(-R2S)의 R1 및 R2가 각각 독립적으로 수소, 또는 나트륨, 칼륨, 칼슘, 리튬 등의 1족 또는 2족 금속, 또는 암모늄(NH4)일 수 있다.(5-mercapto-tetrazol-1-yl) -sulfonic acid or its salt represented by the above formula (3) is 7-aminocephalosporranic acid represented by the above formula (2) or the 3rd group of the cefem ring of the salt thereof as reactant to be introduced into said three-Devonian the substitution reaction of methoxy groups, R 1 of tetra jolhwan 1 Devonian methyl sulfonic groups (-SO 3 R 1) and 5 Devonian a thiol group (-R 2 S) in (tetrazole ring) And R 2 may each independently be hydrogen or a Group 1 or Group 2 metal such as sodium, potassium, calcium, lithium, or ammonium (NH 4 ).

상기 알칸설폰산 용매는, 상기 반응의 반응용매 역할을 하는 것으로서, 탄소수 1 내지 2 개의 저급 알칸설폰산을 제한 없이 사용할 수 있으며, 바람직하게는 메탄설폰산을 사용할 수 있다. 상기 알칸설폰산을 용매로 사용하면, 물, 물/유기용매의 혼합물, 또는 아세토니트릴, 니트로메탄, 초산 또는 이들의 혼합물을 반응용매로서 사용하는 것에 비해 반응의 수율을 높이고, 부반응을 저하시켜 최종생성물의 순도를 향상시킬 수 있다.The alkanesulfonic acid solvent, which serves as a reaction solvent of the reaction, may be used without limitation to lower carbon alkanesulfonic acid having 1 to 2 carbon atoms, preferably methanesulfonic acid may be used. When the alkanesulfonic acid is used as the solvent, the yield of the reaction is increased and the side reactions are lowered compared to using water, a mixture of water / organic solvent, or acetonitrile, nitromethane, acetic acid, or a mixture thereof as a reaction solvent. Purity of the product can be improved.

상기 삼불화붕소 또는 그 착물은 상기 반응에 있어서 루이스산으로 작용하여 반응의 수율을 더욱 개선하는 역할을 하는 것으로서, 통상적으로 사용되는 삼불화붕소 또는 그 착물을 제한 없이 사용할 수 있으며, 비한정적으로는 디알킬에테르(dialkyl ether)와의 착염, 아민(amines)과의 착염, 초산 등의 지방족산(aliphatic acid)과의 착염, 니트릴(nitriles)과의 착염, 카르복실에스테르와의 착염을 예시할 수 있으며, 바람직하게는 디알킬에테르와의 착염인 삼불화붕소 디에틸에테르를 사용할 수 있다.The boron trifluoride or a complex thereof acts as a Lewis acid in the reaction to further improve the yield of the reaction, and can be used without limitation, boron trifluoride or a complex that is commonly used, without limitation Complex salts with dialkyl ethers, salts with amines, salts with aliphatic acids such as acetic acid, salts with nitriles, and salts with carboxyl esters. And boron trifluoride diethyl ether, which is preferably a complex salt with a dialkyl ether, can be used.

상기 화학식 3으로 표시되는 (5-머캅토-테트라졸-1-일)-설폰산 또는 그 염의 함량은 상기 화학식 2로 표시되는 7-아미노세팔로스포란산 또는 그 염 1몰에 대하여 1몰 내지 3몰인 것이 바람직하며, 더욱 바람직하게는 1 내지 1.5몰을 사용할 수 있다. 1몰 미만이면 반응이 완결되지 않고, 3몰을 초과하면 과량의 투입에 따른 미반응물의 부반응으로 인하여 부생성물이 다량 생김으로서, 생성물의 수율 및 순도가 저하될 염려가 있다. 상기 알칸설폰산의 함량은 7-아미노세팔로스포란산 또는 그 염 1몰에 대하여 5 내지 20몰인 것이 바람직하다. 만일 5몰 미만이면 반응성이 저하될 염려가 있고, 20몰을 초과하면 반응의 완결 후, 반응물을 정제하기 위한 중화 반응에 사용되는 암모니아수 등의 염기성 화합물의 사용량의 증가로 반응물의 순도가 저하되는 문제가 있다. 삼불화붕소 또는 그 착물의 함량은 7-아미노세팔로스포란산 또는 그 염 1몰에 대하여 5 내지 10몰인 것이 바람직하다. 만약 5몰 미만이면 반응속도가 늦어 공정시간이 길어지고, 부반응으로 인한 부생성물이 증가하여 반응물의 수율이 저하되며, 10몰을 초과하면 반응물을 정제하기 위한 중화 반응에 사용되는 암모니아수 등의 염기성 화합물의 사용량의 증가로 반응물의 순도가 저하되는 문제점이 있다.The content of (5-mercapto-tetrazol-1-yl) -sulfonic acid or salt thereof represented by Formula 3 is 1 mol relative to 1 mol of 7-aminocephalosporranic acid or salt thereof represented by Formula 2 above. It is preferable that it is 1-3 mol, More preferably, 1-1.5 mol can be used. If the amount is less than 1 mole, the reaction is not completed. If the amount is more than 3 mole, a large amount of by-products are generated due to side reactions of the unreacted substances due to the excessive input, which may lower the yield and purity of the product. The content of the alkanesulfonic acid is preferably 5 to 20 moles with respect to 1 mole of 7-aminocephalosporanic acid or salts thereof. If less than 5 moles, the reactivity may be lowered. If more than 20 moles, after completion of the reaction, the purity of the reactants may be lowered due to an increase in the amount of basic compounds such as ammonia water used in the neutralization reaction for purifying the reactants. There is. It is preferable that the content of boron trifluoride or its complex is 5-10 mol with respect to 1 mol of 7-amino cephalosporranic acid or its salt. If the amount is less than 5 moles, the reaction rate is slow, and the process time is long, and the by-products from the side reactions increase, and the yield of the reactants is reduced. There is a problem in that the purity of the reactants is lowered due to the increase in the amount of.

상기 반응으로 생성되는 상기 화학식 1로 표시되는 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 또는 그 염은 세펨환의 7번기인 아미노기가 염산, 황산, p-톨루엔설폰산, 메탄설폰산 등의 산과 반응하여 생성되는 염을 포함할 수 있다.The 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cef-4-carboxylic acid or salt thereof represented by Chemical Formula 1 produced by the reaction is the 7th group of the cefem ring. Amino groups may include salts produced by reaction with acids such as hydrochloric acid, sulfuric acid, p-toluenesulfonic acid, methanesulfonic acid, and the like.

상기 반응은 -20 내지 80℃의 온도 및 상압 하에서, 20분 내지 5시간 동안 수행할 수 있다. 반응온도가 -20℃ 미만이거나 80℃를 초과하면 부반응으로 인한 부생성물의 증가로 반응물의 수율이 저하된다. 반응시간이 20분 미만이면 반응이 완결되지 않으며, 5시간을 초과하면 공정시간만 길어질 뿐 별다른 장점이 없다.The reaction may be performed at a temperature of −20 to 80 ° C. and atmospheric pressure for 20 minutes to 5 hours. If the reaction temperature is lower than -20 ° C or higher than 80 ° C, the yield of the reactants decreases due to an increase in byproducts due to side reactions. If the reaction time is less than 20 minutes, the reaction is not completed, if it exceeds 5 hours, only the process time is long, there is no particular advantage.

다음으로 반응이 완결된 후, 반응물에 물, 유기용매 또는 이들의 혼합물을 첨가한 후, 상기 용매가 첨가된 반응물에 염기성 화합물을 넣고, 30분 내지 3시간 동안 숙성시켜 상기 화학식 1로 표시되는 반응물인 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 또는 그 염을 결정화시킨다.Next, after completion of the reaction, water, an organic solvent or a mixture thereof is added to the reactants, a basic compound is added to the reactant to which the solvent is added, and the reactants represented by Chemical Formula 1 are aged for 30 minutes to 3 hours. Phosphorus 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cefe-4-carboxylic acid or salt thereof is crystallized.

상기 유기용매로는 통상적으로 사용하는 알코올계 화합물 등의 유기용매를 제한 없이 사용할 수 있으며, 비한정적인 예로는 메탄올, 에탄올, 이소프로판올, 프로판올, n-부탄올, 2-부탄올, 이소부탄올, t-부탄올, 아세톤, 테트라하이드로퓨란, 1,4-디옥산 및 이들의 혼합물을 예시할 수 있으며, 바람직하게는 무기염 등의 부생성물을 제거하여 반응물의 함량 및 순도가 저하되는 것을 막기 위해, 물과 알코올계 화합물의 혼합액을 사용할 수 있다. 상기 유기용매의 함량은 7-아미노 세팔로스포란산 또는 그 염 1g에 대해 1 내지 50ml인 부피/중량비(ml/g)인 것이 바람직하며, 10 내지 20 배의 부피/중량비이면 더욱 바람직하다. 1 부피/중량비 미만이면 반응물의 순도가 저하될 염려가 있고, 50부피/중량비를 초과하면 결정화속도가 느려 공정시간만 길어질 뿐 별다른 장점이 없다. 물/알코올계 화합물의 혼합비율은 어느 용매에 대해서도 다른 용매가 1 내지 50 부피비의 범위 내인 것이 바람직하고, 1 내지 10 부피비면 더욱 바람직하다. 상기 범위를 벗어나면 혼합의 효과가 미미하고, 특히 반응물의 수율 및 순도가 저하될 염려가 있다. As the organic solvent, organic solvents such as alcohol-based compounds that are commonly used may be used without limitation, and non-limiting examples include methanol, ethanol, isopropanol, propanol, n-butanol, 2-butanol, isobutanol, t-butanol , Acetone, tetrahydrofuran, 1,4-dioxane and mixtures thereof may be exemplified. Preferably, water and alcohols are removed to remove the by-products such as inorganic salts, thereby reducing the content and purity of the reactants. A mixed solution of a system compound can be used. The content of the organic solvent is preferably a volume / weight ratio (ml / g) of 1 to 50 ml with respect to 1 g of 7-amino cephalosporranic acid or a salt thereof, and more preferably 10 to 20 times the volume / weight ratio. If it is less than 1 volume / weight ratio, there is a concern that the purity of the reactant is lowered, and if it exceeds 50 volume / weight ratio, the crystallization rate is slow and only the process time is long, there is no particular advantage. It is preferable that the other solvent is in the range of 1-50 volume ratio with respect to any solvent, and, as for the mixing ratio of a water / alcohol type compound, it is more preferable if it is 1-10 volume ratio. Outside the above range, the effect of mixing is insignificant, in particular, there is a fear that the yield and purity of the reactants are lowered.

상기 염기성 화합물은 반응물의 수소이온농도(pH)를 조절하는 역할을 하는 것으로서, 상기 염기성 화합물로는 통상적으로 사용하는 것을 제한 없이 사용할 수 있고, 비한정적으로는 아민, 암모니아, 디에틸아민, 트리에틸아민 및 이들의 혼합물을 예시할 수 있으며, 바람직하게는 암모니아를 사용할 수 있다. 상기 염기성 화합물의 함량은 상기 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 또는 그 염의 결정화 속도 등의 결정화 조건에 의존하는데, 바람직하게는 반응물의 pH가 0 내지 7, 더욱 바람직하게는 1 내지 4가 되도록 사용할 수 있다. 만약 반응물의 pH가 상기 범위를 벗어나면 반응의 수율이 저하될 염려가 있다.The basic compound serves to control the hydrogen ion concentration (pH) of the reactants, and the basic compound can be used without limitation, conventionally used, without limitation, amine, ammonia, diethylamine, triethyl Amines and mixtures thereof can be exemplified, preferably ammonia. The content of the basic compound depends on crystallization conditions such as the crystallization rate of the 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cef-4-carboxylic acid or salts thereof, Preferably the pH of the reactants can be used to be 0 to 7, more preferably 1 to 4. If the pH of the reactants is out of the above range there is a fear that the yield of the reaction is lowered.

상기 결정화 단계는 세포니시드 중간체의 통상적인 결정화 공정 조건 하에서 수행할 수 있으며, 예를 들면 0℃의 온도 하에서, 2시간 동안 수행할 수 있다The crystallization step may be carried out under the usual crystallization process conditions of the cenisid intermediate, for example, at a temperature of 0 ℃, can be carried out for 2 hours.

또한, 필요에 따라 상기 결정화된 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 또는 그 염을 포함한 반응물을 여과한 후, 물, 유기용매 또는 이들의 혼합물로 세척하고, 건조하여 고순도의 상기 화학식 1로 표시되는 화합물인 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 또는 그 염을 제조할 수 있으며, 최종 목적물의 순도를 더욱 높이기 위하여, 액체크로마토그래피 등을 사용하여 최종생성물을 정제할 수도 있다. 상기 반응물의 세척은 상기 결정화 단계에서 사용할 수 있는 유기용매로서, 바람직하게는 메탄올 및 아세톤을 사용할 수 있으며, 일 예로서 반응물을 순차로 물, 메탄올 및 아세톤로 세척하여 수행할 수 있다.Further, if necessary, the reaction product containing the crystallized 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cef-4-carboxylic acid or salts thereof is filtered and then water , 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cef-4-, a compound represented by Chemical Formula 1, washed with an organic solvent or a mixture thereof and dried to obtain high purity. Carboxylic acids or salts thereof may be prepared, and the final product may be purified using liquid chromatography or the like to further increase the purity of the final target product. The washing of the reactant is preferably an organic solvent that can be used in the crystallization step, preferably methanol and acetone. For example, the reactant may be sequentially washed with water, methanol and acetone.

이하, 하기 실시예에 의하여 본 발명을 더욱 상세하게 설명하기로 하나, 본 발명의 범위가 하기 실시예에 의하여 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples, but the scope of the present invention is not limited by the following examples.

[실시예 1] 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 및 그 염류의 제조 Example 1 Preparation of 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cefe-4-carboxylic acid and salts thereof

반응기에 메탄설폰산 400ml 및 삼불화붕소 디에틸에테르 320ml를 넣고, 반응물의 온도를 0℃로 냉각시킨 후, 냉각된 반응물에 상기 화학식 2로 표시되는 7-아미노세팔로스포란산 100g 및 (5-머캅토-테트라졸-1-일)-메탄설폰산 84.4g을 첨가하여 4시간동안 반응을 수행하였다. 반응이 완결된 후, 반응물에 정제수 1500ml 및 메탄올 1500ml를 서서히 적가하고, 0℃에서, 상기 적가된 반응물에 암모니아수를 가하여 반응물의 pH를 2.0으로 하여 2시간 동안 반응물을 결정화하였고, 결정화된 반응물을 여과하였으며, 여과된 반응물을 순차적으로 물, 메탄올 및 아세톤으로 세척한 후, 건조하여 생성물인 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 148g을 얻었고(수율: 98.6%), 고성능 액체크로마토그래피를 사용하여 고순도의 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산을 제조하였다(순도: 99%이상).  400 ml of methanesulfonic acid and 320 ml of boron trifluoride diethyl ether were added to the reactor, and the temperature of the reactant was cooled to 0 ° C., and then 100 g of 7-aminocephalosporanic acid represented by the formula (2) and (5 The reaction was carried out for 4 hours by adding 84.4 g of -mercapto-tetrazol-1-yl) -methanesulfonic acid. After the reaction was completed, 1500 ml of purified water and 1500 ml of methanol were slowly added dropwise to the reaction, and at 0 ° C., ammonia water was added to the added reaction to crystallize the reactant for 2 hours at pH 2.0 of the reactant, and the crystallized reactant was filtered. The filtered reaction was washed sequentially with water, methanol and acetone, and then dried to give the product 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cefe-4-car 148 g of acid was obtained (yield: 98.6%), and high-purity 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cepem-4-carboxyl was obtained using high performance liquid chromatography. Acid was prepared (purity: 99% or more).

[비교예 1] 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 및 그 염류의 제조 Comparative Example 1 Preparation of 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cefe-4-carboxylic acid and salts thereof

반응기에 정제수 500ml, 및 중탄산나트륨 21.0g를 넣고, 상기 화학식 2로 표시되는 7-아미노세팔로스포란산 27.2g 및 정제수 500ml,와 아세톤 250ml의 혼합 용액을 첨가한 후, 반응물의 온도를 45℃로 올리고, (5-머캅토-테트라졸-1-일)-메탄설폰산 29.3g 및 아세톤 1000ml 혼합용액을 45℃를 유지하면서 서서히 적가하고, 반응물의 pH를 7.4 내지 7.6로 유지하면서 2시간동안 환류시키며 반응을 수행하였다. 반응이 완결된 후, 반응물을 0℃로 냉각하고, 냉각된 반응물에 묽은 염산을 가하여 반응물의 pH를 4.0으로 만든 후, 반응물을 결정화하였다. 결정화된 반응물을 여과하고, 여과된 반응물을 아세톤으로 세척한 후, 건조하여 생성물인 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 28.5g을 얻었고(수율: 70%), 고성능 액체크로마토그래피를 사용하여 고순도의 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산을 제조하였다(순도: 95%).500 ml of purified water and 21.0 g of sodium bicarbonate were added to the reactor, and a mixed solution of 27.2 g of 7-aminocephalosporanic acid represented by the formula (2), 500 ml of purified water, and 250 ml of acetone was added thereto, and the temperature of the reactant was 45 ° C. 29.3 g of (5-mercapto-tetrazol-1-yl) -methanesulfonic acid and 1000 ml of acetone were slowly added dropwise while maintaining the temperature at 45 ° C., and the reaction was maintained at 7.4 to 7.6 for 2 hours. The reaction was carried out at reflux. After the reaction was completed, the reaction was cooled to 0 ° C., diluted hydrochloric acid was added to the cooled reaction to bring the pH of the reaction to 4.0, and the reaction was crystallized. The crystallized reactant was filtered off, the filtered reactant was washed with acetone and dried to yield the product 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cepem-4-carboxyl. 28.5 g of acid were obtained (yield: 70%), and high-purity 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cef-4-carboxyl was obtained using high performance liquid chromatography. Acid was prepared (purity: 95%).

[비교예 2] 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 및 그 염류의 제조 Comparative Example 2 Preparation of 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cefe-4-carboxylic acid and salts thereof

반응기에 아세토니트릴 140ml, 상기 화학식 2로 표시되는 7-아미노세팔로스포란산 27.2g, (5-머캅토-테트라졸-1-일)-메탄설폰산 29.3g 및 삼불화붕소 디에틸에테르 42.6g을 순차적으로 넣고, 반응물의 온도를 50℃로 상승시킨 후, 2시간 동안 교반하면서 반응을 수행하였다. 반응이 완결된 후, 반응물을 0℃로 냉각시켰고, 냉각된 반응물에 정제수 140ml를 첨가하고, 암모니아수로 넣어 반응물의 pH를 4.0으로 만든 상태에서, 2시간 동안 반응물을 결정화시켰다. 결정화된 반응물을 여과하고, 아세톤으로 세척한 후 건조하여 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 33g을 얻었고(수율: 81%), 고성능 액체크로마토그래피를 사용하여 고순도의 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산을 제조하였다(순도: 92%). 140 ml of acetonitrile in the reactor, 27.2 g of 7-aminocephalosporanic acid represented by the formula (2), 29.3 g of (5-mercapto-tetrazol-1-yl) -methanesulfonic acid and 42.6 of boron trifluoride diethyl ether g was added sequentially and the temperature of the reaction was raised to 50 ° C., followed by stirring for 2 hours. After the reaction was completed, the reaction was cooled to 0 ° C., and 140 ml of purified water was added to the cooled reaction, and the reaction was crystallized for 2 hours while the pH of the reaction was adjusted to 4.0 by adding ammonia water. The crystallized reaction was filtered, washed with acetone and dried to give 33 g of 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cefe-4-carboxylic acid (yield: 81%), using high performance liquid chromatography to prepare high purity 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cepem-4-carboxylic acid (purity: 92 %).

본 발명에 따른 세포니시드 중간체 또는 그 염의 제조방법은, 반응의 수율이 높고 부반응이 적어 고순도의 세포니시드 중간체 또는 그 염을 제조할 수 있는 장점이 있고, 또한 간단한 정제과정만으로 고순도의 세포니시드 중간체 또는 그 염을 경제적으로 제조할 수 있다는 장점이 있다.The method for producing a cell nisid intermediate or a salt thereof according to the present invention has the advantage of producing a high purity cell nisid intermediate or a salt thereof with high yield of reaction and less side reactions, and also a high purity cell nitrile by a simple purification process. There is an advantage that the seed intermediate or salt thereof can be economically prepared.

Claims (6)

알칸설폰산 용매 및 삼불화붕소 또는 그 착물의 존재하에서, 하기 화학식 2로 표시되는 7-아미노세팔로스포란산 또는 그 염과 하기 화학식 3으로 표시되는 (5-머캅토-테트라졸-1-일)-설폰산 또는 그 염을 반응시키는 단계; 및In the presence of an alkanesulfonic acid solvent and boron trifluoride or a complex thereof, 7-aminocephalosporane acid represented by the following formula (2) or its salt and (5-mercapto-tetrazol-1- represented by the following formula (3): Reacting the 1) -sulfonic acid or salt thereof; And 상기 반응물에 물, 유기용매 또는 이들의 혼합물, 및 염기성 화합물을 첨가하여 반응물을 결정화하는 단계를 포함하는 하기 화학식 1로 표시되는 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 및 그 염의 제조방법.7-amino-3- [1-sulfomethyltetrazol-5-ylthio represented by the following Chemical Formula 1, which comprises crystallizing the reactant by adding water, an organic solvent or a mixture thereof, and a basic compound to the reactant. Methyl] -3-cepem-4-carboxylic acid and its salt. [화학식 1][Formula 1] [화학식 2][Formula 2] [화학식 3][Formula 3] 상기 화학식 1 내지 3에서, R1 및 R2는 각각 독립적으로 H, Na, K, NH4, Ca, Li이다.In Formulas 1 to 3, R 1 and R 2 are each independently H, Na, K, NH 4 , Ca, Li. 제 1 항에 있어서, 상기 화학식 1로 표시되는 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 또는 그 염, 및 상기 화학식 2로 표시되는 7-아미노세팔로스포란산 또는 그 염은 세펨환의 7번기인 아미노기가 염산, 황산, p-톨루엔설폰산, 메탄설폰산 등의 산과 반응하여 생성된 염인 것인 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 또는 그 염의 제조방법.The compound according to claim 1, wherein 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cef-4-carboxylic acid or a salt thereof is represented by Formula 1, and Formula 2 above. 7-Aminocephalosporanic acid or a salt thereof is 7-amino-3, wherein an amino group of the cefme ring is a salt produced by reacting with an acid such as hydrochloric acid, sulfuric acid, p-toluenesulfonic acid, and methanesulfonic acid. -[1-Sulfomethyltetrazol-5-ylthiomethyl] -3-cefe-4-carboxylic acid or a salt thereof. 제 1 항에 있어서, 상기 반응단계의 온도는 -20 내지 80℃이고, 반응시간은 20분 내지 5시간인 것인 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 및 그 염의 제조방법.According to claim 1, wherein the temperature of the reaction step is -20 to 80 ℃, the reaction time is 20 minutes to 5 hours 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cefem-4-carboxylic acid and its salt. 제 1 항에 있어서, 상기 알칸설폰산은 메탄설폰산이고, 메탄설폰산의 함량은 상기 7-아미노세팔로스포란산 또는 그 염 1몰에 대하여 5 내지 20몰인 것인 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 및 그 염의 제조방법.The method of claim 1, wherein the alkanesulfonic acid is methanesulfonic acid, and the content of methanesulfonic acid is 5 to 20 mol based on 1 mol of the 7-aminocephalosporonic acid or salts thereof. 1-Sulfomethyltetrazol-5-ylthiomethyl] -3-cefe-4-carboxylic acid and a salt thereof. 제 1 항에 있어서, 상기 삼불화붕소 또는 그 착물은 삼불화붕소 디에틸에테르이고, 상기 삼불화붕소 디에틸에테르의 함량은 상기 7-아미노세팔로스포란산 또는 그 염 1몰에 대하여 5 내지 10몰인 것인 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 및 그 염의 제조방법.The method of claim 1, wherein the boron trifluoride or a complex thereof is boron trifluoride diethyl ether, and the content of the boron trifluoride diethyl ether is 5 to 1 mole of the 7-aminocephalosporranic acid or salt thereof. A method for producing 7-amino-3- [1-sulfomethyltetrazol-5-ylthiomethyl] -3-cefe-4-carboxylic acid and salts thereof having 10 moles. 제 1 항에 있어서, 상기 결정화 단계에서 사용되는 용매는, 물, 메탄올, 에탄올 및 이들의 혼합물로 구성되는 군으로부터 선택되는 것인 7-아미노-3-[1-설포메틸테트라졸-5-일티오메틸]-3-세펨-4-카르복실산 및 그 염의 제조방법.The 7-amino-3- [1-sulfomethyltetrazol-5-yl according to claim 1, wherein the solvent used in the crystallization step is selected from the group consisting of water, methanol, ethanol and mixtures thereof. Thiomethyl] -3-cepem-4-carboxylic acid and its salt.
KR1020040034929A 2004-05-17 2004-05-17 novel process for producing cefonicid intermediate KR100589559B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020040034929A KR100589559B1 (en) 2004-05-17 2004-05-17 novel process for producing cefonicid intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040034929A KR100589559B1 (en) 2004-05-17 2004-05-17 novel process for producing cefonicid intermediate

Publications (2)

Publication Number Publication Date
KR20050110103A true KR20050110103A (en) 2005-11-22
KR100589559B1 KR100589559B1 (en) 2006-06-14

Family

ID=37285670

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020040034929A KR100589559B1 (en) 2004-05-17 2004-05-17 novel process for producing cefonicid intermediate

Country Status (1)

Country Link
KR (1) KR100589559B1 (en)

Also Published As

Publication number Publication date
KR100589559B1 (en) 2006-06-14

Similar Documents

Publication Publication Date Title
EP1562957B1 (en) Process for the preparation of 3-propenyl cephalosporin dmf solvate
WO2004046154A1 (en) Novel amorphous hydrate of a cephalosporin antibiotic
KR101109177B1 (en) Penam crystal and process for producing the same
EP1813619B1 (en) Process for producing penam compound
CN108084212B (en) Preparation method of cefditoren pivoxil
KR100589559B1 (en) novel process for producing cefonicid intermediate
CN108033971B (en) Method for synthesizing cefcapene pivoxil hydrochloride
KR20020068517A (en) Crystals of penicillin and process for the production thereof
KR100343434B1 (en) Method of preparing 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid
CN108299470B (en) Preparation method of cefteram pivoxil
US7476760B2 (en) Purification and production methods of 1-aminocyclopropanecarboxylic acid
CN108017658B (en) Synthesis method of cefprozil
CN111253405B (en) Preparation method of biapenem intermediate
KR101170192B1 (en) One-pot process for producing 1,2-benzisoxazole-3-methanesulfonamide
CN114805394A (en) Synthesis method of cefixime
KR100477763B1 (en) The Novel preparation of Intermediate of Cefatrizine Propylene gylcol
JP4529116B2 (en) Method for producing high-purity tritylpiperazine derivative
KR100388108B1 (en) New process for producing intermediates of cephalosporin antibiotics
KR100749163B1 (en) Method for producing derivatives of 7?-methoxyoxacephem
JP3302417B2 (en) Method for producing 3-alkoxymethyl-cephalosporin derivative
KR970004047B1 (en) Novel process for the preparation of cephem compound
KR20120078687A (en) Process for the preparation of cephalosporin intermediate using new enzyme
US20220041574A1 (en) Pyrazole amine reactive crystallization
KR20110070523A (en) Process for the preparation of cephalosporin intermediate using new enzyme
CN110878071A (en) Preparation method of α -amino-gamma-butyrolactone and salt thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120601

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee